Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	23.24	11.29	14.69	9.6	34.89	32.67
Short-Term Investments	99.56	140.23	24.79	31.82	-	-
Cash & Short-Term Investments	122.8	151.52	39.49	41.42	34.89	32.67
Cash Growth	316.81%	283.70%	-4.67%	18.74%	6.79%	230.45%
Receivables	0.06	10.37	10.37	0.55	0.39	0.06
Prepaid Expenses	1.27	1.5	1	0.92	1.16	0.96
Total Current Assets	124.13	163.39	50.86	42.89	36.44	33.68
Property, Plant & Equipment	8.93	6.87	7.61	6.94	4.62	0.85
Other Intangible Assets	-	-	-	-	-	0
Other Long-Term Assets	0.51	0.22	0.27	0.27	0.28	0.09
Total Assets	133.57	170.48	58.73	50.09	41.33	34.62
Accounts Payable	4.8	8.18	6.24	4.83	3.12	2.72
Accrued Expenses	7.37	0.01	0.01	0.09	0.6	0.01
Current Portion of Long-Term Debt	-	-	-	-	-	0.25
Current Portion of Leases	0.85	0.83	0.75	0.68	0.42	-
Current Unearned Revenue	12	12	24.27	17.98	-	-
Other Current Liabilities	3.38	-	-	-	-	-
Total Current Liabilities	28.4	21.03	31.27	23.59	4.13	2.97
Long-Term Debt	-	-	-	-	-	0.07
Long-Term Leases	0.19	0.62	1.49	1.88	2.45	-
Long-Term Unearned Revenue	-	-	-	9.47	-	-
Other Long-Term Liabilities	-	3.38	3.38	3.38	3.38	3.38
Total Liabilities	28.59	25.02	36.13	38.31	9.96	6.42
Common Stock	0.05	0.05	0.03	0.03	0.02	0.02
Additional Paid-In Capital	353.68	344.22	181.7	148.74	139.4	116.22
Retained Earnings	-250.14	-199.83	-159.37	-137.08	-108.06	-88.04
Comprehensive Income & Other	1.39	1.03	0.24	0.11	-	-
Shareholders' Equity	104.98	145.46	22.6	11.79	31.37	28.2
Total Liabilities & Equity	133.57	170.48	58.73	50.09	41.33	34.62
Total Debt	1.04	1.45	2.24	2.56	2.87	0.32
Net Cash (Debt)	121.76	150.06	37.25	38.86	32.01	32.35
Net Cash Growth	340.74%	302.84%	-4.14%	21.38%	-1.03%	227.23%
Net Cash Per Share	2.88	4.26	1.39	1.58	1.39	2.08
Filing Date Shares Outstanding	45.72	45.68	31.4	25.26	24.3	22.8
Total Common Shares Outstanding	45.71	45.58	31.15	25.24	24.19	20.58
Working Capital	95.73	142.36	19.59	19.3	32.3	30.71
Book Value Per Share	2.30	3.19	0.73	0.47	1.30	1.37
Tangible Book Value	104.98	145.46	22.6	11.79	31.37	28.2
Tangible Book Value Per Share	2.30	3.19	0.73	0.47	1.30	1.37
Machinery	7.52	6.51	5.64	4.38	0.04	1.52
Leasehold Improvements	2.78	2.5	2.13	1.39	2.51	0.05

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q